# Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis

> **NCT01547091** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Alliancells Bioscience Corporation Limited** · enrollment: 200 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)
- **DRUG:** Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs)
- **BIOLOGICAL:** UC-MSC+DMARDS

## Key facts

- **NCT ID:** NCT01547091
- **Lead sponsor:** Alliancells Bioscience Corporation Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2014-10
- **Final completion:** 2014-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01547091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01547091, "Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01547091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*